title: Untangling the immunological implications of nadir on CD4+ cell recovery during suppressive highly active antiretroviral therapy.
authors.forename: Laurenzia
authors.initials: L
authors.lastname: Ferraris
authors.forename: Giusi Maria
authors.initials: GM
authors.lastname: Bellistri
authors.forename: Valentina
authors.initials: V
authors.lastname: Pegorer
authors.forename: Camilla
authors.initials: C
authors.lastname: Tincati
authors.forename: Luca
authors.initials: L
authors.lastname: Meroni
authors.forename: Massimo
authors.initials: M
authors.lastname: Galli
authors.forename: Antonella d'Arminio
authors.initials: Ad
authors.lastname: Monforte
authors.forename: Andrea
authors.initials: A
authors.lastname: Gori
authors.forename: Giulia
authors.initials: G
authors.lastname: Marchetti
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology*; D006706:Homeostasis; D006801:Humans